Issued Patents All Time
Showing 1–24 of 24 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12172989 | Histone acetyltransferase (HAT) inhibitor and use thereof | Cheng LUO, Hualiang Jiang, Yaxi Yang, Lianghe Mei, Wenchao Lu +5 more | 2024-12-24 |
| 12151204 | Catalytic oxidation system for efficient conversion and removal of volatile organic compounds (VOCs) in coal chemical industry, and catalytic oxidation method thereof | Shengyong Lu, Yaqi PENG, Minghui Tang, Kai Zhang, Hao Zhang +2 more | 2024-11-26 |
| 12065447 | Heterocyclic amide for inhibiting RIP1 kinase and uses thereof | Wei Tang, Xiangbo Yang, Huimin Lu, Mengying Gao, Yaxi Yang +1 more | 2024-08-20 |
| 11911477 | Use of fructose in preparing drug for treating ischemic injury | Xunming JI, Jing Liang, Panpan Yu, Rongrong Han | 2024-02-27 |
| 11548899 | Fused 1,4-oxazepines and related analogs as BET bromodomain inhibitors | Shaomeng Wang, Yang Hu, Chao-Yie Yang, Chong Qin | 2023-01-10 |
| 11498927 | Heterocyclic amide for inhibiting RIP1 kinase and uses thereof | Wei Tang, Xiangbo Yang, Huimin Lu, Mengying Gao, Yaxi Yang +1 more | 2022-11-15 |
| 11466028 | Fused 1,4-oxazepines as BET protein degraders | Shaomeng Wang, Yang Hu, Chong Qin, Fuming Xu, Jiantao Hu +4 more | 2022-10-11 |
| 11427593 | Bromodomain inhibitor compound and use thereof | Cheng LUO, Zizhou Li, Yaxi Yang, Shijie Chen, Hong Ding +4 more | 2022-08-30 |
| 11319303 | Compound used as autophagy regulator, and preparation method therefor and uses thereof | Cheng LUO, Yuli Xie, Zhiyi Yao, Liyan Yue, Wei Wan +4 more | 2022-05-03 |
| 11192898 | MDM2 protein degraders | Shaomeng Wang, Yangbing Li, Jiuling Yang, Angelo Aguilar, Jiantao Hu +3 more | 2021-12-07 |
| 11013745 | Triazolopyrimidine, triazolopyridine compounds, and the composition thereof for treating PRC2-mediated diseases | Cheng LUO, Yaxi Yang, Yuanyuan Zhang, Daohai Du, Hualiang Jiang +2 more | 2021-05-25 |
| 10975093 | Fused 1,4-diazepines as BET protein degraders | Shaomeng Wang, Yang Hu, Chong Qin, Fuming Xu, Jiantao Hu +1 more | 2021-04-13 |
| 10759808 | Monofunctional intermediates for ligand-dependent target protein degradation | Shaomeng Wang, Yangbing Li, Angelo Aguilar, Jiantao Hu, Fuming Xu +8 more | 2020-09-01 |
| 10689434 | Antibody against hepatitis B surface antigen and use thereof | Wenxin Luo, Juan Zhang, Quan Yuan, Tianying ZHANG, Jun Zhang +1 more | 2020-06-23 |
| 10633386 | BET protein degraders | Shaomeng Wang, Fuming Xu, Jiantao Hu, Longchuan Bai, Chao-Yie Yang | 2020-04-28 |
| 10391175 | BET bromodomain inhibitors and therapeutic methods using the same | Shaomeng Wang, Xu Ran, Yujun Zhao, Chao-Yie Yang, Liu Liu +10 more | 2019-08-27 |
| 10307407 | 9H-pyrimido [4,5-B] indoles as BET bromodomain inhibitors | Shaomeng Wang, Yujun Zhao, Angelo Aguilar | 2019-06-04 |
| 10253044 | 9H-pyrimido [4,5-b]indoles and related analogs as BET bromodomain inhibitors | Shaomeng Wang, Yujun Zhao, Angelo Aguilar, Liu Liu, Longchuan Bai +11 more | 2019-04-09 |
| 9675697 | BET bromodomain inhibitors and therapeutic methods using the same | Shaomeng Wang, Xu Ran, Yujun Zhao, Chao-Yie Yang, Liu Liu +10 more | 2017-06-13 |
| 9580430 | 9H-pyrimido[4,5-B]indoles and related analogs as BET bromodomain inhibitors | Shaomeng Wang, Yujun Zhao, Angelo Aguilar, Liu Liu, Longchuan Bai +11 more | 2017-02-28 |
| 9403892 | Therapeutic TRAIL fusion protein and preparation and use thereof | Yu Zhou, Jing Jiang | 2016-08-02 |
| 8163783 | Ribonucleotide reductase inhibitors and methods of use | Yun Yen, David Horne, Yate-Ching Yuan, Angela L. Perkins Harki, Leila Su | 2012-04-24 |
| 7956076 | Ribonucleotide reductase inhibitors and methods of use | Yun Yen, David Horne, Yate-Ching Yuan, Angela L. Perkins Harki, Leila Su | 2011-06-07 |
| 7078485 | N-terminal modified recombinant human endostatin and its production | Yongzhang Luo, Zhuobing Zhang | 2006-07-18 |